Liposomes: Quo vadis?

Pharmaceutical Science and Technology Today

Volumn 1, Issue 1, 1998, Pages 19-31

  Storm, Gert ^a   Crommelin, Daan J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RESEARCH; REVIEW;

EID: 0032052587     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(98)00007-8     Document Type: Article

References (60)

1. 1 Crommelin, D.J.A. and Storm, G. (1990) in Comprehensive Medicinal Chemistry (Vol. 5) (Sammes, P.G. and Taylor, J.D., eds), pp. 601-701, Pergamon Press
2. 2 Bakker-Woudenberg, I.A.J.M. (1995) Adv. Drug Deliv. Rev. 17, 5-20
3. 3 Daemen, T. et al. (1995) Adv. Drug Deliv. Rev. 17, 21-30
4. 4 Killion, J.J. and Fidler, I.J. (1994) Immunomethods 4, 273-279
5. 5 Ten Hagen, T.L.M., Van Vianen, W. and Bakker-Woudenberg, I.A.J.M. (1995) J. Infect. Dis. 171, 385-392
6. 6 Gregoriadis, G. (1994) Immunomethods 4, 210-216
7. 7 Alving, C.R. (1995) Ann. New York Acad. Sci. 754, 143-152
8. 8 Kersten, G.F. and Crommelin, D.J.A. (1995) Biochim. Biophys. Acta 1241, 117-138
9. 9 Bergers, J.J., Storm, G. and Den Otter, W. (1993) in Liposome Technology (Vol. 2, 2nd edn) (Gregoriadis, G., ed.), pp. 141-166, CRC Press
10. 10 Gluck, R. (1995) Pharm. Biotechnol. 6, 325-345
11. 11 Gluck, R. et al. (1992) J. Clin. Invest. 90, 2491-2495
12. 12 Woodle, M.C. and Storm, G., eds (1998) Long Circulating Liposomes: Old Drugs, New Therapeutics, Springer-Verlag
13. 13 Storm, G. et al. (1995) Adv. Drug Deliv. Rev. 17, 31-48
14. 14 Vingerhoeds, M.H., Storm, G. and Crommelin, D.J.A. (1994) Immunomethods 4, 259-272
15. 15 Lasic, D.D. and Templeton, N.S. (1996) Adv. Drug Deliv. Rev. 20, 221-266
16. 16 Mahato, R.I., Rolland, A. and Tomlinson, E. (1997) Pharm. Res. 14, 853-859
17. 17 Zuidam, N.J., Grit, M. and Crommelin, D.J.A. (1993) in Liposome Technology (Vol. 1, 2nd edn) (Gregoriadis, G., ed.), pp. 455-486, CRC Press
18. 18 Zuidam, N.J., Talsma, H. and Crommelin, D.J.A. (1996) in Handbook of Nonmedical Applications of Liposomes. From Design to Microreactors (Vol. 3) (Barenholz, Y. and Lasic, D.D., eds), pp. 71-80, CRC Press
19. 19 Cullis, P.R. et al. (1997) Biochim. Biophys. Acta 1331, 187-211
20. 20 Haran, G. et al. (1993) Biochim. Biophys. Acta 1151, 201-205
21. 21 Grit, M., Zuidam, N.J. and Crommelin, D.J.A. (1993) in Liposome Technology (Vol. 1, 2nd edn) (Gregoriadis, G., ed.), pp. 455-486, CRC Press
22. 22 Van Winden, E.C.A. and Crommelin, D.J.A. (1997) Eur. J. Pharm. Biopharm. 43, 295-307
23. 23 Van Hoogevest, P. and Fankhauser, P. (1989) in Liposomes in the Therapy of Infectious Diseases and Cancer (Lopez-Berestein, G. and Fidler, I.J., eds), pp. 453-466, Alan R. Liss
24. 24 Barenholz, Y. and Crommelin, D.J.A. (1994) in Encyclopedia of Pharmaceutical Technology (Swarbrick, J., ed.), pp. 1-39, Marcel Dekker
25. 25 Zonneveld, G.M. and Crommelin, D.J.A. (1988) in Liposomes as Drug Carriers: Recent Trends and Progress (Gregoriadis, G., ed.), pp. 795-817, J. Wiley and Sons
26. 26 Storm, G. et al. (1993) in Liposome Technology (Vol. 3, 2nd edn), pp. 345-383, CRC Press
27. 27 Storm, G. et al. Clin. Cancer Res. (in press)
28. 28 Blume, G. et al. (1993) Biochim. Biophys. Acta 1149, 180-184
29. 29 Maruyama, K. et al. (1997) Adv. Drug Deliv. Rev. 24, 235-242
30. 30 Klibanov, A.L. (1998) in Long Circulating Liposomes: Old Drugs, New Therapeutics (Woodle, M.C. and Storm, G., eds), pp. 269-286, Springer-Verlag
31. 31 Allen, T.M. et al. (1994) J. Liposome Res. 4, 1-25
32. 32 Szoka, F.C. and Tang, M. (1993) J. Liposome Res. 3, 363-375
33. 33 Storm, G. and Van Etten, E. (1997) Eur. J. Clin. Microbiol. Infect. Dis. 16, 64-73
34. 34 Gabizon, A. and Papahadjopoulos, D. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 6949-6953
35. 35 Gabizon, A. (1995) Adv. Drug Deliv. Rev. 16, 285-294
36. 36 Forssen, E.A. (1997) Adv. Drug Deliv. Rev. 24, 133-150
37. 37 Jain, R.K. (1997) Adv. Drug Deliv. Rev. 26, 71-90
38. 38 Gabizon, A. and Muggia, F.M. (1998) in Long Circulating Liposomes: Old Drugs, New Therapeutics (Woodle, M.C. and Storm, G., eds), pp. 165-174, Springer-Verlag
39. 39 Bergers, J.J., Den Otter, W. and Crommelin, D.J.A. (1996) J. Liposome Res. 6, 339-355
40. 40 Koppenhagen, F. (1997) Liposomes as Delivery Systems for Recombinant Interleukin-2 in Anticancer Immunotherapy, pp. 125-135, Thesis Utrecht Unversity, Utrecht, The Netherlands
41. 41 Hart, B.A. et al. (1997) FEBS Lett. 409, 91-95
42. 42 Boerman, O.C. et al. (1995) J. Nucl. Med. 36, 1639-1644
43. 43 Boerman, O.C. et al. (1998) in Long Circulating Liposomes: Old Drugs, New Therapeutics (Woodle, M.C. and Storm, G., eds), pp. 229-240, Springer-Verlag
44. 44 Oyen, W.J.G. et al. (1996) J. Nucl. Med. 37, 1392-1397
45. 45 Bakker-Woudenberg, I.A.J.M. et al. (1993) J. Infect. Dis. 168, 164-171
46. 46 Bakker-Woudenberg, I.A.J.M. et al. (1995) J. Infect. Dis. 171, 938-947
47. 47 Kedar, E. et al. (1994) J. Immunother. 16, 115-124
48. 48 Kedar, E. et al. (1997) J. Immunother. 20, 180-193
49. 49 Woodle, M.C. et al. (1992) Pharm. Res. 9, 260-265
50. 50 Peeters, P.A.M. et al. (1989) Biochim. Biophys. Acta 981, 269-276
51. 51 Niculescu-Duvaz, I. and Springer, C.J. (1997) Adv. Drug Deliv. Rev. 26, 151-172
52. 52 Bagshawe, K.D. et al. (1995) Tumor Targeting 1, 17-29
53. 53 Storm, G. et al. (1997) Adv. Drug Deliv. Rev. 24, 225-231
54. 54 Vingerhoeds, et al. (1993) FEBS Lett. 336, 485-490
55. 55 Ledley F.D. (1996) Pharm. Res. 13, 1595-1614
56. 56 Lasic, D.D. (1996) Science & Medicine 3, 34-43
57. 57 Woodle, M.C. et al. (1990) Proc. Int. Symp. Control. Rel. Bioact. Mater., pp. 77-78, CRS
58. 58 Klibanov, A.L. and Huang, L. (1992) J. Liposome Res. 2, 321-334
59. 59 Guo, L.S.S. et al. (1991) Int. J. Pharm. 75, 45-54
60. 60 Janoff, A.S. et al. (1993) J. Liposome Res. 3, 451-471